{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:32:29Z","timestamp":1786739549539,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Glycemic control is the major therapeutic objective in diabetes. Poor glycemic control in diabetes mellitus can be prevented by using rational use of anti-diabetic medication, which needs to be evaluated for effectiveness by prescription pattern studies. The objective of this study was to assess the prescribing pattern and adherence to the American Diabetic Association\u2019s (ADA) treatment guidelines in type 2 diabetes mellitus patients in a tertiary care teaching hospital in Uttarakhand, India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>This cross-sectional study was conducted on 206 type 2 diabetic patients who were prescribed anti-diabetic therapy. Patient\u2019s demographic details and drugs prescribed, with their dosage, were recorded to study the prescription pattern.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Oral anti-diabetic drugs were most commonly prescribed in 149 (72.33%) type 2 diabetic mellitus patients. Five of these patients (3.35%) were on metformin monotherapy, whereas majority of patients (81, 54.36%) were on a fixed dose combination of Glimepiride (SU) + Metformin (MET). Forty-five patients (30.20%) were on MET + Dipeptidyl peptidase 4 inhibitors (DPP4I) combination; 5 (3.35%) were on MET + SU + alpha-glucosidase inhibitors (AGI) combination; 7 (4.69%) were on MET + SU + Pioglitazone (PIO) (Thiazolidinediones) combination; 6 (4.02%) were on sodium\/glucose cotransporter-2 inhibitors (SGLT2I) and 57 (27.66%) were on insulin therapy. Out of 206 patients, the prescriptions of 185 patients (89.8%) were adherent and of 21 patients (10.19%) were not adhering to ADA 2021 treatment guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Oral anti-diabetic agents predominate the prescribing pattern practices for type 2 DM but there was a shift in trend towards the use of fixed-dose combinations (FDC) in the management of type 2 DM, and majority of prescriptions were adherent to ADA treatment guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_458_22","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T05:53:22Z","timestamp":1667973202000},"page":"6159-6164","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Prescribing pattern of anti-diabetic drugs and adherence to the American Diabetes Association\u2019s (ADA) 2021 treatment guidelines among patients of type 2 diabetes mellitus: A cross-sectional study"],"prefix":"10.4103","volume":"11","author":[{"given":"Kalpana","family":"Tiwari","sequence":"first","affiliation":[{"name":"Department of Pharmacology, AIIMS Rishikesh, Rishikesh, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Bisht","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, AIIMS Rishikesh, Rishikesh, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Kant","sequence":"additional","affiliation":[{"name":"Department of General Medicine, AIIMS Rishikesh, Rishikesh, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra S.","family":"Handu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, AIIMS Rishikesh, Rishikesh, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"R1-20260527","doi-asserted-by":"crossref","first-page":"125","DOI":"10.18311\/ajprhc\/2021\/27517","article-title":"analysis of prescribing pattern, efficacy and adverse drug reactions of anti-diabetic agents in type-2 diabetic patients at a tertiary care teaching hospital","volume":"13","author":"Kumar","year":"2021","journal-title":"Asian J Pharm Res Health Care"},{"key":"R2-20260527","doi-asserted-by":"crossref","first-page":"251","DOI":"10.18203\/2319-2003.ijbcp20210555","article-title":"Prescribing pattern of antidiabetic drugs in tertiary care hospital","volume":"10","author":"Kumar Pothuru","year":"2021","journal-title":"Int J Basic Clin Pharmacol"},{"key":"R3-20260527","first-page":"111","article-title":"Standards of medical care in diabetes\u20142021","volume":"1","year":"2021","journal-title":"Diabetes Care"},{"key":"R4-20260527","doi-asserted-by":"crossref","first-page":"669","DOI":"10.18203\/2320-6012.ijrms20190915","article-title":"A prospective study on drug utilization pattern of anti-diabetic drugs in a tertiary care teaching hospital of eastern Uttar Pradesh, India","volume":"7","author":"Pankaj","year":"2019","journal-title":"Int J Res Med Sci"},{"key":"R5-20260527","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/ijem.IJEM_646_18","article-title":"Drug prescription patterns and cost analysis of diabetes therapy in India:Audit of an endocrine practice","volume":"23","author":"Singla","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"key":"R6-20260527","first-page":"440","article-title":"Drug utilisation study in geriatric type 2 diabetic patients","volume":"1","author":"Rajeshwari","year":"2007","journal-title":"J Clin Diagn Res"},{"key":"R7-20260527","first-page":"5","article-title":"Prescription pattern analysis of antidiabetic drugs in diabetes mellitus and associated comorbidities","volume":"8","author":"Mahmood","year":"2017","journal-title":"Clin Investig"},{"key":"R8-20260527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26611\/10101111","article-title":"A study of drug utilization pattern of antihyperglycemic agents in diabetes mellitus cases of a rural Telangana population","volume":"11","author":"Dhananjay","year":"2019","journal-title":"Med Pulse Int J Pharmacol"},{"key":"R9-20260527","first-page":"485","article-title":"Pattern of antidiabetic drugs use in type-2 diabetic patients in a medicine outpatient clinic of a tertiary care teaching hospital","volume":"31","author":"Patel","year":"2017","journal-title":"Int J Basic Clin Pharmacol"},{"key":"R10-20260527","first-page":"1","article-title":"Assessment of prescription pattern of antidiabetic drugs in the outpatient department of a tertiary care hospital","volume":"3","author":"Kakade","year":"2017","journal-title":"Int J Clin Endocrinol Metab"},{"key":"R11-20260527","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.18203\/2319-2003.ijbcp20162219","article-title":"A drug utilization and pharmacoeconomic study of anti-diabetic drugs prescribed to type 2 diabetes mellitus patients visiting the medicine out-patient department of a tertiary care hospital of north India","volume":"5","author":"Singh","year":"2016","journal-title":"Int J Basic Clin Pharmacol"},{"key":"R12-20260527","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.12991\/mpj.2017.24","article-title":"Prescribing pattern of antidiabetic drugs in type 2 diabetic patients of Noakhali city in Bangladesh","volume":"21","author":"Chowdhury","year":"2017","journal-title":"Marmara Pharm J"},{"key":"R13-20260527","first-page":"44","article-title":"A prospective study on prescribing pattern in type 2 diabetes mellitus outpatients in a tertiary care institution","volume":"4","author":"Hans","year":"2020","journal-title":"Int J Med Sci Diagn Res"},{"key":"R14-20260527","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/0976-0105.121653","article-title":"Evaluation of antidiabetic prescriptions, cost and adherence to treatment guidelines:A prospective, cross-sectional study at a tertiary care teaching hospital","volume":"4","author":"Acharya","year":"2013","journal-title":"J Basic Clin Pharm"},{"key":"R15-20260527","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.3346\/jkms.2021.36.e230","article-title":"Treatment patterns of type 2 diabetes assessed using a common data model based on electronic health records of 2000-2019","volume":"36","author":"Lee","year":"2021","journal-title":"J Korean Med Sci"},{"key":"R16-20260527","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.phrs.2017.12.001","article-title":"Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials","volume":"129","author":"Coppolino","year":"2018","journal-title":"Pharmacol Res"},{"key":"R17-20260527","doi-asserted-by":"crossref","first-page":"221","DOI":"10.15537\/smj.2015.2.9603","article-title":"Adherence to the American Diabetes Association standards of care among patients with type 2 diabetes in primary care in Saudi Arabia","volume":"36","author":"Harbi","year":"2015","journal-title":"Saudi Med J"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_458_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:29:55Z","timestamp":1786735795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_458_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_458_22","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"2022-02-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}